Literature DB >> 15653994

Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis.

Maria Plataki1, Anastassios V Koutsopoulos, Katherine Darivianaki, George Delides, Nikolaos M Siafakas, Demosthenes Bouros.   

Abstract

STUDY
OBJECTIVE: Idiopathic pulmonary fibrosis (IPF) is a chronic, usually fatal lung disease of unknown etiology. A common feature is the presence of microscopic areas of epithelial cell dropout. Increased apoptosis of these cells could elucidate the speculative pathogenesis of the disease. Therefore, the aim of our study was to examine the expression of p53, p21, bcl-2, bax, and caspase-3 in association with DNA strand breaks in bronchial and alveolar epithelial cells in lung specimens from IPF patients and control subjects. PATIENTS AND METHODS: We examined by immunohistochemistry the expression of p53, p21, bax, bcl-2, and caspase-3 in association with DNA strand breaks detected by terminal deoxynucleotide transferase-mediated deoxyuridine triphosphate-biotin nick end-labeling (TUNEL) in bronchial and alveolar epithelial cells in lung specimens taken by biopsy in 12 IPF patients and 10 control subjects. An independent tissue evaluation by two pathologists graded semiquantatively the degree of staining present.
RESULTS: TUNEL was positive in epithelial cells in all IPF patients and only in one control subject. The expression of p53, p21, bax, and caspase-3 was up-regulated in IPF patients compared to control subjects. Bcl-2 was expressed less in IPF patients than in control subjects.
CONCLUSIONS: These results confirm that apoptotic hyperplastic epithelial cells are present in patients with IPF and that the expression of p53, p21, bax, and caspase-3 appears to be up-regulated and that of bcl-2 down-regulated in these cells. The increased expression of proapoptotic molecules in epithelial cells in IPF may be involved in the inadequate and delayed reepithelialization, which in turn contributes to fibroblast proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653994     DOI: 10.1378/chest.127.1.266

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  89 in total

Review 1.  The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.

Authors:  Rachel S Knipe; Andrew M Tager; James K Liao
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 2.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 3.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

4.  Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.

Authors:  Sreerama Shetty; Thirunavukkarasu Velusamy; Steven Idell; Praveenkumar Shetty; Andrew P Mazar; Yashodhar P Bhandary; Rashmi S Shetty
Journal:  Mol Cell Biol       Date:  2007-06-04       Impact factor: 4.272

5.  Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Kazuhisa Konishi; Kevin F Gibson; Kathleen O Lindell; Thomas J Richards; Yingze Zhang; Rajiv Dhir; Michelle Bisceglia; Sebastien Gilbert; Samuel A Yousem; Jin Woo Song; Dong Soon Kim; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2009-04-10       Impact factor: 21.405

Review 6.  The role of the endoplasmic reticulum protein calreticulin in mediating TGF-β-stimulated extracellular matrix production in fibrotic disease.

Authors:  Benjamin Y Owusu; Kurt A Zimmerman; Joanne E Murphy-Ullrich
Journal:  J Cell Commun Signal       Date:  2017-10-28       Impact factor: 5.782

7.  Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis.

Authors:  Sandra Cabrera; Mariana Maciel; Iliana Herrera; Teresa Nava; Fabián Vergara; Miguel Gaxiola; Carlos López-Otín; Moisés Selman; Annie Pardo
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

8.  Altered expression of p63 isoforms and expansion of p63- and club cell secretory protein-positive epithelial cells in the lung as novel features of aging.

Authors:  Jutaro Fukumoto; Sahebgowda Sidramagowda Patil; Sudarshan Krishnamurthy; Smita Saji; Irene John; Venkata Ramireddy Narala; Helena Hernández-Cuervo; Matthew Alleyn; Mason T Breitzig; Lakshmi Galam; Ramani Soundararajan; Uddhav K Chaudhari; Barbara C Hansen; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Cell Physiol       Date:  2019-01-16       Impact factor: 4.249

9.  Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.

Authors:  Khondoker M Akram; Nicola J Lomas; Nicholas R Forsyth; Monica A Spiteri
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis.

Authors:  Norihiko Sakai; Andrew M Tager
Journal:  Biochim Biophys Acta       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.